FDA
-
-
-
-
-
-
-
Oruka Therapeutics Announces IND Clearance for EVERLAST-A Phase 2a Trial of ORKA-001 in Psoriasis with Phase 1 Data to be Presented at EADV in September
-
322,979 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

